Reading this clinical breakthrough? See how real patients are applying these numbers in real life. Compare real-world patient outcomes, lab numbers, and doctor visit tips—100% free with a private @handle and zero login wall.
Click to Ask a Question or Post Your Experience ▾
Post to Gut, Labs & Supplements Space (15 Seconds • No Account or Email Required)
Or read existing discussions in Gut, Labs & Supplements Space →
★ Breakthrough Medical Research • 15 Landmark Multi-Trial Guides • 6,280 Indexed Studies

Longevity, Cellular Aging, Vaccines & Preventive Medicine — Clinical Trial Breakdowns & PubMed Evidence

Long-term human survival cohorts and Phase 3 prevention trials covering UKPDS 34 / TAME Metformin AMPK longevity pathways, muscle protein synthesis across eight decades of life, and adult vaccine coadministration trials. Explore 817 indexed studies and multi-trial syntheses with verified PubMed PMIDs, participant sample sizes (N), and Absolute vs. Relative Risk numbers.

★ #1 Lead Breakthrough Study • NEJM SURMOUNT-1 (176 Weeks) N = 1,032 Adults • p < 0.001

Once-Weekly Tirzepatide Cuts Type 2 Diabetes Progression by 94% Over 3 Years—With a 22.9% Sustained Weight Reduction

The Plain-English Receipt: Only 1.2% of prediabetic adults on Tirzepatide progressed to Type 2 diabetes over 3.4 years vs. 19.3% on placebo (Absolute Risk Reduction = 18.1% • Number Needed to Treat = 6).

Two biomedical scientists in white lab coats inside a sunlit medical research laboratory pipetting clinical assay samples and reviewing trial results
Inside the Clinical Evidence Lab: Our research desk audits 6,280 human trials from NEJM, The Lancet, JAMA, and NCBI PubMed—reporting true Absolute Risk Reduction (ARR) and sample sizes (N) without pharma spin.
3. All Indexed Clinical Studies (817)

Longevity, Aging & Prevention — Clinical Trials & Study Reports (817)

Page 6 of 28 • Sorted by Participant Sample Size (N)
Randomized Controlled Trial N = 110

Eltrombopag during induction chemotherapy in older patients with newly diagnosed acute myeloid leukemia is safe and reduces platelet transfusion requirements: The EPAG-2015 French Innovative Leukemia Organization phase 2 randomized trial (N = 110)

This study failed to demonstrate a survival advantage after eltrombopag addition, at variance with previous reports, but shows that initiating eltrombopag after chemotherapy washout is feasible and safe, and resulted in a decreased need for platelet transfusions.

Cancer • 2026-11-01 Read Study
Randomized Controlled Trial PMID 42978043

Randomized Controlled Trial: Exploratory serum renal biomarker and eGFR responses to high-protein diets during resistance versus concurrent training in resistance-trained men

In resistance-trained men, 16 weeks of high protein intake did not produce statistically detectable differences in renal biomarker or eGFR changes compared with moderate protein intake, irrespective of training modality.

Journal of the International Society of Sports Nutrition • 2026-12-30 Read Study
Randomized Controlled Trial PMID 42990082

Randomized Controlled Trial: Development and evaluation of a subjective measurement of geographical hardness-to-reach: a survey of data collectors in a large-scale cluster randomised trial of azithromycin mass drug administration

Our findings indicate acceptable feasibility and reliability, with moderate convergent and predictive validity. This simple survey can serve as a useful tool for evaluating hard-to-reach areas and guiding resource allocation in public health interventions, including mass drug administration campaigns.

Journal of global health • 2026-11-06 Read Study
Randomized Controlled Trial PMID 42984166

Randomized Controlled Trial: Efficiency of Rescue Paramedic Hoist versus Underslung Antenna in Helicopter-Based Avalanche Searches

This randomized, experimental field trial comparing two currently used standard search procedures in the Norwegian SAR service showed that the RP Hoist Search was significantly more efficient than the Antenna Search for localizing buried avalanche victims, reducing total localization time by more than two minutes.

Prehospital and disaster medicine • 2026-11-05 Read Study
Randomized Controlled Trial PMID 42982936

Randomized Controlled Trial: Resistance training and protein supplementation in patients with incurable gastroesophageal cancer

Resistance training combined with protein supplementation was not feasible during first-line chemotherapy in patients with incurable gastroesophageal cancer due to low accrual and low adherence to protein supplementation.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer • 2026-11-05 Read Study
Randomized Controlled Trial PMID 42986046

Randomized Controlled Trial: [The design process and protocol for a cognitive-behavioral intervention to reduce electronic cigarette use among university students]

The protocol will provide preliminary evidence on the feasibility and initial evaluation of an intervention aimed at reducing electronic cigarette use, generating information to inform the design of future studies and prevention strategies for the Mexican university student population.

Revista espanola de salud publica • 2026-11-05 Read Study
Randomized Controlled Trial PMID 42966369

Supervised physiotherapeutic scoliosis-specific exercises provide limited additional benefit at 24 months in braced adolescents with idiopathic scoliosis

Supervised PSSE provided a statistically significant but clinically modest radiological benefit over self-directed exercise. This did not translate into a higher likelihood of clinically meaningful radiological improvement. No sustained clinically meaningful quality-of-life benefit was shown.

The bone & joint journal • 2026-11-01 Read Study
Meta-Analysis & Systematic Review PMID 42969980

Drug-drug interactions between statins and antibiotics

Clinicians should exercise caution when prescribing such combinations, particularly in high-risk patients. Further large-scale studies are needed to better quantify risk across different statins and antibiotic classes.

Indian journal of pharmacology • 2026-11-01 Read Study
Meta-Analysis & Systematic Review PMID 42960561

Meta-Analysis: Endpoint-specific mortality associated with malignancy among adults with sepsis or septic shock

Malignancy was associated with higher mortality among adults with sepsis or septic shock, with variation across mortality endpoints and clinical contexts. These findings support endpoint-specific prognostic assessment and highlight the need for future studies to incorporate more granular cancer characteristics.

Annals of medicine • 2026-10-24 Read Study
Evidence Methodology, PubMed Verification & YMYL Standards

Frequently Asked Questions About dotMD Clinical Trial Breakdowns

Why does dotMD report both Absolute Risk Reduction (ARR) and Relative Risk Reduction (RRR) on clinical trials?

Traditional health headlines often exaggerate findings by reporting only Relative Risk Reduction—for example, claiming a drug cuts risk by 50% when the event rate dropped from 2% to 1% (an Absolute Risk Reduction of just 1.0 percentage point, meaning 100 patients must take the drug for 1 person to benefit, or NNT = 100). On dotMD, every flagship study breakdown reports both Relative Risk and Absolute Risk alongside the exact sample size (N) and trial duration.

How does dotMD separate human randomized controlled trials (RCTs) from animal or observational studies?

Every study on dotMD displays its exact Study Design Tier at the top of the card (Phase 3 Randomized Trial, Randomized Controlled Trial, Meta-Analysis & Systematic Review, Multi-Trial Clinical Evidence Synthesis, Journal Watch Cohort, or FDA Safety Alert) along with the human participant count (N). Preclinical mouse or cell-culture data is never presented as human clinical proof.

Why did dotMD replace synthetic "Study Rigor Scores" with primary PubMed PMIDs and trial metadata?

Arbitrary 0-to-100 rigor scores obscure what actually makes a study trustworthy. Instead of synthetic scores, dotMD surfaces the verifiable primary evidence signals: exact NCBI PubMed IDs (PMID), ClinicalTrials.gov registration numbers (NCT), double-blind vs. crossover design, sample size (N), p-values / Hazard Ratios, and study limitations.

How do dotMD Research Breakdowns connect to Conditions, Medications, Supplements, and Specialist Doctors?

Medical research is only useful if you can act on it safely with your clinician. Every flagship research synthesis links directly to the parent Condition diagnostic cutoff guide, the Medication FDA DailyMed & CMS NADAC wholesale price ledger, the Supplement elemental weight decoder, and our High-CPT-Volume Specialist Directory.